{
    "nct_id": "NCT06179160",
    "official_title": "A Phase 1, Open-Label, Multicenter Study of INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation",
    "inclusion_criteria": "* ≥18 years old\n* Locally-advanced or metastatic solid tumor with KRAS G12D mutation\n* For Part 1 and Part 2 Combination Groups 1 and 2: Disease progression on prior standard treatment, intolerance to or ineligibility for standard treatment, or no available standard treatment to improve the disease outcome\n* For Part 2 Combination Groups 3 and 4: No more than 1 prior standard treatment\n* Cohort specific requirements as follows:\n\n  * Parts 1A and 1D: Histologically or cytologically confirmed malignant solid tumor of any tissue origin\n  * Part 1B\n\n    * Disease group 1: diagnosis of PDAC and ≤ 2 prior standard systemic regimens for pancreatic cancer\n    * Disease group 2: diagnosis of CRC\n    * Disease group 3: diagnosis of NSCLC\n    * Disease group 4: diagnosis of other advanced solid tumor and not part of Disease groups 1, 2 or 3\n  * Part 1c: Confirmed diagnosis of PDAC, CRC, or NSCLC\n  * Parts 2A and 2B\n\n    * Combination 1: Diagnosis of PDAC or Diagnosis of CRC and\n\n      * Prior treatment in the advanced setting with a fluoropyrimidine-based chemotherapy regimen containing either oxaliplatin or irinotecan and\n      * In Part 2a: ≤ 3 prior standard regimens\n      * In Part 2b: ≤ 2 prior standard regimens\n    * Combination 2: Diagnoses of PDAC, CRC or NSCLC\n    * Combination Group 3 (INCB161734 in combination with GEMNabP) and Combination Group 4 (INCB161734 in combination with mFOLFIRINOX):\n\n      * Diagnosis of PDAC\n      * ≤ 1 prior standard systemic regimen for pancreatic cancer\n* Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Prior treatment with any KRAS G12D inhibitor\n* Known additional invasive malignancy within 1 year of the first dose of study drug\n* History of organ transplant, including allogeneic stem cell transplantation\n* Significant, uncontrolled medical condition\n* History or presence of an ECG abnormality\n* Inadequate organ function\n\nOther protocol-defined Inclusion/Exclusion Criteria may apply",
    "miscellaneous_criteria": ""
}